or Try an Advanced Search...

    Technical Analysis for SILO - Silo Pharma, Inc.

    Grade Last Price % Change Price Change
    D 0.93 -1.98% -0.02
    SILO closed down 2.56 percent on Wednesday, November 20, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SILO trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -1.98%
    Wide Bands Range Expansion -1.98%
    Down 3 Days in a Row Weakness -1.98%
    Down 4 Days in a Row Weakness -1.98%
    Lower Bollinger Band Touch Weakness -1.98%
    Oversold Stochastic Weakness -1.98%
    NR7 Range Contraction -4.48%
    Lower Bollinger Band Walk Weakness -4.48%
    Stochastic Reached Oversold Weakness -4.48%
    Wide Bands Range Expansion -4.48%
    Older End-of-Day Signals for SILO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 1 hour ago
    Fell Below Lower Bollinger Band about 1 hour ago
    Down 3% about 2 hours ago
    Down 2 % about 3 hours ago
    Lower Bollinger Band Support about 3 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SILO Chart by TradingView
    Basic chart:

    Profile

    Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders

    Is SILO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
    Nov 15 Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023)
    Oct 31 Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
    Sep 10 Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
    Aug 21 Silo Pharma files for secondary stock offering
    Aug 14 Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
    Aug 7 Silo Pharma announces partnership with global CRO for central nervous system homing peptide
    Aug 7 Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
    Jul 26 Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
    Jul 22 Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    See more SILO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.46
    52 Week Low 0.841
    Average Volume 123,026
    200-Day Moving Average 1.50
    50-Day Moving Average 1.10
    20-Day Moving Average 1.14
    10-Day Moving Average 1.14
    Average True Range 0.11
    RSI (14) 36.71
    ADX 15.01
    +DI 15.01
    -DI 24.29
    Chandelier Exit (Long, 3 ATRs) 1.03
    Chandelier Exit (Short, 3 ATRs) 1.25
    Upper Bollinger Bands 1.33
    Lower Bollinger Band 0.94
    Percent B (%b) 0.01
    BandWidth 34.53
    MACD Line -0.03
    MACD Signal Line 0.00
    MACD Histogram -0.028
    Fundamentals Value
    Market Cap 2.73 Million
    Num Shares 2.89 Million
    EPS -1.40
    Price-to-Earnings (P/E) Ratio -0.68
    Price-to-Sales 62.64
    Price-to-Book 0.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.06
    Resistance 3 (R3) 1.07 1.04 1.04
    Resistance 2 (R2) 1.04 1.01 1.04 1.04
    Resistance 1 (R1) 0.99 0.99 0.98 0.99 1.03
    Pivot Point 0.96 0.96 0.95 0.96 0.96
    Support 1 (S1) 0.91 0.93 0.90 0.91 0.86
    Support 2 (S2) 0.88 0.91 0.88 0.85
    Support 3 (S3) 0.83 0.88 0.85
    Support 4 (S4) 0.83